|
CME Outfitters |
Share:
|
OverviewSince 2002, CME Outfitters has delivered over 1,400 innovative evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to primary care, specialty audiences and community-based clinicians with strong expertise in neuroscience, gastroenterology, dermatology, rheumatology, immunology, virology, transplant, and cardiology. CME Outfitters is certified as a women’s business enterprise through the Women’s Business Enterprise National Council (WBENC), the nation’s largest third-party certifier of businesses owned and operated by women in the United States. |
Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis Management
Osteoarthritis (OA) is the most common form of arthritis, affecting 1 in 3 people over the age of 65. It is the third most rapidly rising cause of disability and the most common reason for decrease in ambulation. With the onset of the COVID-19 pandemic, the US Surgeon General has recommended cancelling elective surgeries, causing a large impact on patients with OA. A survey of 360 patients at 6 ...
|
|
Adding Tools to the Toolbox: New and Emerging Treatments for Psoriatic Arthritis
The principles of psoriatic arthritis (PsA) treatment include reducing pain, improving quality of life, preventing structural damage and complications, engaging patients in shared decision-making, and identifying comorbidities that may impact treatment decisions. This requires management by a multidisciplinary team. Novel agents and treatment targets have demonstrated efficacy in PsA. Education ...
|
|
Addressing Racial Disparities in Patients with Schizophrenia: Making the Commitment to Do Better
Schizophrenia is a persistent, debilitating disease that depletes individuals and their families of their general well-being, as well as psychosocial and cognitive functioning. Compounding its impact, racial disparities exist in the diagnosis and management of schizophrenia, resulting in racially and ethnically diverse individuals being less likely to have access to mental health services, seek ...
|
|
Adopting a Tailored Approach to Managing Unmet Needs in Osteoarthritis
Previously, osteoarthritis (OA) was thought to be a disease of chronic overload and impaired biomechanics on the joint that lead to the destruction of the joint's article cartilage, resulting in inflammation. However, evolving theories link OA to complex inflammatory and metabolic factors, and inadequate pain relief with current treatments is a common aspect of OA treatment which is responsible ...
|
|
All Hands: Integrating a Teams Approach to Risk-Benefit Individualization of Rheumatoid Arthritis and Psoriatic Arthritis Therapy
This CME Outfitters OnDemand webcast focuses on integrating a multidisciplinary approach to treating PsA and RA through case-based learning, with expert faculty discussing management strategies and how to integrate shared decision-making (SDM) into practice to facilitate appropriate treatment selection and empower patients.
At the end of this CE activity, participants should be able to:
- In...
|
|
As We Age: Considering the Impact of Renal Impairment When Choosing an HIV Pre-Exposure Prophylaxis (PrEP) Formulation
Lack of knowledge about PrEP remains a major barrier for optimal PrEP uptake. Furthermore, knowledge of PrEP and long-term risk mitigation related to renal impairment and use in individuals with medical comorbidities is necessary for improving widespread uptake. This is particularly important in aging individuals who are at risk for contracting HIV, as they may have medical comorbidities and ris...
|
|
Best Practices for Incorporating LAIs into Treatment Planning for Schizophrenia
Schizophrenia is an all-too-often chronic, debilitating disorder that impedes quality of life and psychosocial functioning. Implementation of effective therapy that promotes sustained recovery often poses a challenge for both clinicians and patients. Long-acting injectables (LAIs) can play a critical role in relapse prevention and rehospitalization, and subsequently, recovery and restoration of ...
|
|
Call to Action for Health Equity: Racial Disparities in the Care of Patients with Cardiometabolic Disease
Cardiovascular disease is the leading cause of death for adults in the US. However, patients from minority populations with cardiovascular disease have disproportionately poor health outcomes and are particularly vulnerable to health disparities. Racial inequities in health also result in higher risk-burden in minority groups for metabolic syndromes such as Type 2 (adult-onset) diabetes, which i...
|
|
Call to Action: Racial Disparities in Maternal Health
The United States ranks 61st in the world for maternal mortality, and African American/Black women are three times more likely to die due to poor maternal health, while Native American women are two times more likely than White women to die. Pregnancy-related mortality is 2.4 times higher than it was in 1987, however, approximately 65% of maternal deaths are preventable. Action steps to mitigate...
|
|
Comprehensive and Coordinated Patient-Centered Care in Psoriatic Arthritis
Understanding patient preferences, values, and needs is essential to patient satisfaction and patient-centered care. Whether via telehealth or in-office treatment, today’s patients and their families want to be engaged in their care. This involves inclusion in personalized decision-making, education about their disease and treatment options, updates on care progress, and arriving at treatment ...
|
|
COVID-19 and Its Impact on Patient Care in IBD: What Clinicians Need to Know
This Live and OnDemand webcast provides clinicians with the latest information and consensus recommendations for the management of patients with IBD during the COVID-19 era. Expert faculty will also examine the latest evidence on treatment and prevention strategies for COVID-19.
At the end of this CE activity, participants should be able to:
-Examine the latest evidence on current and emergi...
|
|
COVID-19 and Its Impact on Patient Care: What Gastroenterologists Need to Know
This Live and OnDemand webcast provides clinicians with the latest information and consensus recommendations for the management of patients with IBD during the COVID-19 era. Expert faculty will also examine the latest evidence on treatment and prevention strategies for COVID-19.
At the end of this CE activity, participants should be able to:
-Apply optimal strategies to manage patients wit...
|
|
Developing an Enhanced Recovery After Surgery (ERAS) Protocol: Best Practices to Reduce Complications in Surgical Patients
Enhanced Recovery after Surgery (ERAS) protocols represent comprehensive, multidisciplinary efforts to expedite postoperative recovery while reducing avoidable complications. Successful implementation of these protocols requires proper coordination between the surgeon, anesthesiologist, nursing personnel, pharmacist, patient, and patient's caregivers in the postoperative period. This has led to ...
|
|
Differentiators When Choosing Novel Treatment Options for EDS
Reducing excessive daytime sleepiness (EDS) is an important treatment goal for patients with narcolepsy or obstructive sleep apnea (OSA). In order to achieve reduced EDS, cataplexy and sleep paralysis/hypnagogic hallucinations must be controlled to improve disturbed nighttime sleep, which then improves fatigue and brain fog and reduces psychosocial dysfunction, therefore improving quality of lif...
|
|
Eliminating Diagnostic Delays in Psoriatic Arthritis
Psoriatic arthritis (PsA) is a progressive, erosive, chronic, heterogeneous, systemic inflammatory disease affecting six different clinical domains and presents in up to 30% of patients with psoriasis (PsO). Beyond issues caused with joints and skin, PsA can also lead to fatigue, poor sleep quality, diminished work capacity, physical function limitations, and decreased social participation. Earl...
|
|
Evidence-Based Strategies to Improve Access to Therapies for Patients with Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is both a rare disease and the most common fatal genetic disease of infancy. The approval of the first disease-modifying therapy (DMT) for SMA in 2016 revolutionized management, and treatment options have expanded with two additional DMTs approved more recently. However, because SMA is a rare disease, many clinicians and payers have limited knowledge of SMA and the ...
|
|
Finding Function: A Holistic Approach to Managing Osteoarthritis
There are several different approaches to treating osteoarthritis (OA), including physical, psychosocial, and mind-body. It is important that primary care physicians work in concert with rheumatologists, physical/occupational therapists, psychologists, and dietitians to create a multidisciplinary management plan for their patients with OA, as well as participating in shared decision-making.
I...
|
|
Finding Your Footing in the Shifting Landscape of Multiple Sclerosis
In this CME Outfitters Live and OnDemand webcast, animated 3-D models will illustrate the immune processes that contribute to MS pathology and serve as targets for immune-directed therapies. Expert faculty will review clinical data supporting the efficacy and safety of novel and emerging immune-directed therapies as well as the role of biomarkers in assessing disease progression and guiding trea...
|
|
From Bench to Bedside: Applying Clinical Updates to Schizophrenia Management
Per APA Guidelines, treatment goals for schizophrenia include avoiding relapses and exacerbations that can cause immense negative impact on quality of life (QoL). Long-acting injectables (LAIs) are an effective tool for achieving these goals in both acute and chronic phases of illness; however, there is often reluctance to implement their use. A better understanding of the safety and efficacy of...
|
|
HBV Treatment Decision-Making
Chronic hepatitis B virus (HBV) is a serious public health concern that is often underrated despite the approval of newer therapies and subsequent updated guidelines. Integrating guideline-directed treatment can reduce the morbidity and mortality associated with HBV.
In this second episode of the four-part CMEOCast Podcast to Practice series "Meeting Patients Where They Live: Community-Based ...
|
|
Hitting Refresh on Excessive Daytime Sleepiness: Managing Patients with Narcolepsy and Idiopathic Hypersomnia
Central disorders of hypersomnia such as narcolepsy and idiopathic hypersomnia (IH) can be debilitating as both disorders are characterized by excessive daytime sleepiness (EDS) which conveys a high degree of disability and burden. While there are safe, effective therapies that promote sustained reduction of symptoms in narcolepsy, there is often a failure to implement them in a timely manner. M...
|
|
How to Use Digital Cognitive Testing Tools to Aid in the Diagnosis of Mild Cognitive Impairment (MCI) and Dementia
Mild cognitive impairment (MCI) is a condition in which individuals demonstrate focal or multifocal impairment with minimal impairment of instrumental activities of daily living (IADL) that does not cross the threshold for dementia diagnosis. It can be the first cognitive expression Alzheimer's disease (AD) or secondary to other disease processes that can cause cognitive deficits. Early diagnosi...
|
|
Immune Pathways in Systemic Lupus Erythematosus (SLE)
Lupus is a prototypic autoimmune disease with highly heterogeneous manifestations and variable disease activity in which no two cases are alike. Differences can be caused by genetics and epigenetics, pathogenetic mechanisms, demographics, ethnicity and race, as well as socioeconomic factors, and disease heterogeneity can cause challenges with development and selection of therapeutics, perfection...
|
|
Implementing a Shingles Protocol in Pharmacies
Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles va...
|
|
Improving Outcomes for Patients with Psoriatic Arthritis: Integrating a Comprehensive, Patient-Centered Care Model into Your Practice
Psoriatic arthritis (PsA), a serious and potentially disabling condition, affects approximately 30% of patients with psoriasis, with the joint involvement often occurring about 10 years after the appearance of skin disease. PsA causes not only physical and functional impairments but also has a negative impact on overall quality of life. While dermatologists have an important role in early detect...
|
|
Initiating Medication-Assisted Therapy for OUD in Diverse Settings: Clinical Pearls for Navigating the Process
The opioid abuse epidemic has resulted in an alarming increase in opioid-related overdoses and deaths; however, the severe and lethal consequences of opioid misuse is preventable with the use of medication-assisted treatment (MAT), which is a proven, effective tool for patients with opioid use disorder (OUD).
Research has demonstrated that MAT is effective in reducing opioid use and overdoses...
|
|
Irregular Care: Racial Inequities in the Management of Cardiac Rhythm Disorders
Structural racism and classism leads to many of the social determinants of health (SDoH) that cause disparities in cardiovascular (CVD) care, such as unequal preventative care, heart arrythmia treatment, and research inclusion. Interpersonal racism, including unconscious bias, worsens disproportionate CVD care, and is also a stand-alone factor for this health inequity. Underrepresented minority ...
|
|
Joining Forces in the Coordination of Care of Patients with Psoriatic Arthritis
Delays in diagnosing psoriatic arthritis (PsA) are common, with the median lag time from disease onset to a confirmatory diagnosis being 2.5 years. It is imperative that clinicians recognize the impact of delays in diagnosis on joint damage and patient quality of life, and that a multidisciplinary approach can help with earlier diagnosis and better management of PsA and its comorbidities.
The...
|
|
Managing Patients with HFrEF Post-Discharge: Discussion of the Latest Evidence
In 2021, new practice guidelines, updated clinical pathways, and a universal definitions and classification document were released to help clinicians better diagnose, stage, and manage patients with heart failure (HF). The recommendations include direction on sequencing foundational therapies and integrating the latest FDA-approved additions to the HF armamentarium – SGLT2 inhibitors and an or...
|
|
Matching Treatment Choice to the Pathophysiology of Sleep
The neurobiology of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) has no identified pathophysiology. This can make it difficult for clinicians to determine a target for therapeutic intervention; therefore, awareness of the mechanisms of action of current and novel therapies is vital when selecting an optimal treatment.
In the second episode of this CME Outfitters podcast...
|
|
Mechanistic Rationales for Novel and Emerging Treatments for Psoriatic Arthritis: Plugging the Data into the Equation
Psoriatic arthritis (PsA) can have serious debilitating effects on peripheral joints, the spine, tendon insertions, and fingers. Management of PsA has improved with therapies such as nonpharmacologic and symptomatic treatments, oral small molecules, tumor necrosis factor inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, CTLA4-lg, Janus kinase (JAK)/TyK2 inhibitors, and IL-23 inhib...
|
|
Myth Busting about NSAIDs and Bone Health
Nonsteroidal anti-inflammatory drugs (NSAIDs) have recently become one of the top post-procedure pain management recommendations, and in most cases, a suitable replacement to the use of opioids. Unfortunately, myths about NSAIDs inhibiting bone healing and increasing fracture risks are prevalent, despite the lack of clinical evidence that NSAIDs impair healing.
The third episode of this CMEOC...
|
|
Pathogenesis of Psoriatic Arthritis: A Broader Understanding to Inform Next Steps
Psoriatic arthritis (PsA) presents in up to 30% of patients with psoriasis (PsO) and may precede, occur concurrently with, or occur after the development of PsO. It is imperative to recognize that PsA can present in the dermatology or rheumatology clinic depending on the primary symptom and that clinicians then accurately diagnose PsA by utilizing screening questionnaires, as well as screening p...
|
|
Promoting Equitable Oral Health in Patients of Color
There are many vulnerable and underserved populations in oral health. Gaps in health and health care are often caused by the disconnect between medical and dental care and a fragmented system that has left 74 million people without dental insurance, leading to knowledge gaps and a lack of dental-medical collaboration and coordination in patient care. These issues are exacerbated in patients of c...
|
|
Rethinking Routines in Multiple Sclerosis Management: What the Future Holds for DMTs and Cognitive Assessment Strategies
Multiple sclerosis (MS) is a chronic inflammatory and neurological disease that is the leading cause of disability in young and middle-aged people in the United States. The number of disease-modifying therapies (DMTs) available for treatment of MS has expanded in recent years, and it is imperative that neurologists and other health care professionals (HCPs) have up-to-date knowledge of clinical ...
|
|
Safety and Efficacy of Emerging Treatments in the Management of Systemic Lupus Erythematosus (SLE)
When measuring outcomes in systemic lupus erythematosus (SLE), it is important for clinicians to monitor disease activity, health-related quality of life, and any irreversible change in the organ system that occurred since the onset of SLE. While there are currently many therapies utilized in treating SLE, such as nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antimalarials, immunosupp...
|
|
Schizophrenia is a Whole-Body Disease: Examining the Impact of Comorbidities on Morbidity and Mortality
Schizophrenia is a clinically complex, multi-system disorder that is associated with an increased incidence of medical comorbidities, complicating management. Overlooked or undermanaged medical comorbidities increase morbidity and all-cause mortality risks. Comprehensive management of medical comorbidities is essential to improve whole patient care and optimize clinical outcomes.
In the first...
|
|
Seeing Osteoarthritis Management Through a New Mechanistic Lens
Inadequate pain relief despite current treatments is one of the most troubling aspects of osteoarthritis (OA), and is responsible for the majority of health care visits in patients with OA. Additional concerns about the risks of long-term NSAID and opiate use contribute to unmet treatment needs. It is therefore necessary for clinicians to recognize the role of novel targets for pain management, ...
|
|
Signals of Change in the Management of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that effects up to 18% of children and up to 10% of adults and can have a substantial negative impact on the quality of life (QoL) of patients and their families. Its management is challenging at any age, with patients and caregivers often becoming overwhelmed by the chronic and relapsing nature of AD. Establishing disease severity i...
|
|
Talking Safety and NSAIDs
There are many myths surrounding the use of nonsteroidal anti-inflammatory drugs (NSAIDs), and while it is important to dispel these myths, it is also imperative to understand what risks might be involved. NSAIDs, like all medications, carry the potential for side effects and other dangers that must be understood for effective use in pain management.
Following the CMEOCast podcast episode tha...
|
|
The Complete Response: Addressing Antidepressant Failure in Patients with Major Depressive Disorder
Major depressive disorder (MDD) is a profoundly debilitating, lifelong disorder. Many patients do not achieve remission with initial first-line antidepressant therapy, which is typically comprised of selective serotonin reuptake inhibitors (SSRIs) or selective norepinephrine reuptake inhibitors (SNRIs). Subsequently, patients endure a high burden of treatment failure, though it is often unrecogn...
|
|
The Epidemic Within the Pandemic: Managing Complications in Populations with Obesity
Obesity is increasingly recognized as a multi-causal chronic disease that leads to structural and physiological abnormalities and functional impairments. Despite the growing prevalence and substantial burden of obesity in terms of health-related quality of life (HRQoL), healthcare utilization, and healthcare costs, obesity remains under-diagnosed and under-treated. The recent recognition that ob...
|
|
The Pediatric Patient with HIV: Translating Data to Practice
When a child is exposed to HIV perinatally, it is imperative that providers be proactive about repeat testing of the mother to assess the child’s risk of HIV even into the third trimester and delivery.
This CMEO BriefCase will introduce Cynthia, who is 24 weeks pregnant and has recently found out that her partner has begun injecting drugs. This case study will focus on the importance of HIV...
|
|
The Role of Race in Health Care Delivery in IBD
Although IBD is more common in non-Hispanic Whites compared to other racial groups, there is a disproportionately higher ratio of hospitalizations, surgery, and IBD-related mortality among non-Hispanic African Americans compared with other racial groups. This fact, in addition to the rising prevalence of IBD in North America and the estimate that 54% of the U.S. population will be comprised of m...
|
|
The Role of Socioeconomic Factors in Health Care Delivery in IBD
Certain patients with IBD are more likely to see poor outcomes due to low socioeconomic status (SES). Recognizing and acting on these differences is especially important during the COVID-19 pandemic, the economic consequences of which have disproportionately affected those with low SES.
In the second episode of this CMEOCast podcast series, expert faculty focus on the role of SES and gender b...
|
|
Unique Approaches to the Management of Underserved Patients with IBD
There are many disparities in irritable bowel disease (IBD) care, with an incidence rate of IBD hospitalization that is 4x higher in patients with low socio-economic status and a 3x increased ratio of IBD hospitalizations and mortality in Blacks compared to Whites and Hispanics.
The final episode of this CMEOCast podcast series summarizes the discussion points on the racial/ethnic and economi...
|
|
Unlocking the Value of Biosimilar Therapies in IBD
Over the years, biologic agents have proven their importance in the management of chronic autoimmune diseases including inflammatory bowel disease (IBD). Biosimilars are molecules highly similar to approved biologic medicines that have been developed to mitigate the high costs of biologics. Despite the fact that these therapies are tested to ensure non-inferiority to originator products, questio...
|
|
Weighing the Heavy Burden of Osteoarthritis: Improving Function and Quality of Life
The burden of osteoarthritis (OA) is a heavy one, often leading to poor quality of life (QoL) due to functional limitations and loss of independence, poor sleep quality, fatigue, depressed mood, and increased healthcare expenditures. Additionally, comorbidities such as stroke, peptic ulcer, and metabolic syndrome must be considered. Therefore, proper assessment of a patient's OA, the pain it cau...
|
|